Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

------------------------------------------------------------

December 11, 2002

U.S. IMMUNIZATION NEWS

"Adverse Events Associated With 17D-Derived Yellow Fever Vaccination--United States, 2001-2002" Journal of the American Medical Association (www.jama.com) (11/27/02) Vol. 288, No. 20,

The Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices received in June 2001 seven reports of yellow fever vaccine-associated viscerotropic disease in patients who received the 17D-derived yellow fever vaccine.  Following the reports, the committee recommended more vigilant monitoring of the vaccine, and a preliminary report of the group's findings in the year from June 2001 has been presented.  Two more cases of viscerotropic disease and four cases of neurotropic disease have been linked in a preliminary manner to the vaccine.  However, because of the vaccines necessity for travelers going to areas in which yellow fever is endemic, the CDC has continued to recommend that travelers obtain the vaccine and that doctors remain aware of any suspicious events after vaccination.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.